All News #Library
Biotech
ACTICOR Adapts Its ACTISAVE Study to Prepare the Registration of Glenzocimab
14 Sep 2023 //
BUSINESSWIRE
Acticor Biotech: Progress in Discussions with EU and US Regulatory Agencies
30 May 2023 //
BUSINESSWIRE
Update on Acticor Biotech`s clinical developments with glenzocimab
09 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support